MedPath
HSA Approval

FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML

SIN15365P

FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML

FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML

November 23, 2017

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

C03CA01

furosemide

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

Baxter Pharmaceuticals India Private Limited

Active Ingredients

Furosemide

50 mg/5 mL

Furosemide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML - HSA Approval | MedPath